Tesamorelin Cost

Prices Compared by Source

Close-up of syringes arranged beside small glass medication vials on a flat surface, as if set out for measured dosing.

Tesamorelin vs Ipamorelin Cost Comparison: Reading the Numbers

A side-by-side look at how tesamorelin and ipamorelin listings price out per vial and per mg, and why the two figures are not directly comparable.

Reviewed by Robert Stern, PharmD, RPh, pharmacist and pharmaceutical researcher ·

Robert Stern, PharmD, RPh is a registered pharmacist with a research background in peptide hormones and GHRH analog formulation, with experience spanning hospital pharmacy and pharmaceutical research environments.

  • tesamorelin
  • ipamorelin
  • pricing
  • cost-comparison

A tesamorelin vs ipamorelin cost comparison only means something once both listings are reduced to the same unit. Tesamorelin and ipamorelin are sold in different vial sizes, at different price tiers, and sometimes in different measurement conventions, so a raw sticker-price comparison between the two tells a reader almost nothing about which listing is actually priced higher per unit of compound. The only way to compare them fairly is to normalize each listing to a shared figure, usually cost per milligram, and hold that figure to the same assumptions on both sides.

Two Compounds, Two Pricing Baselines

Tesamorelin and ipamorelin are categorized differently by most sellers, and that categorization shapes how each is priced before any comparison even starts. Tesamorelin listings are typically built around larger single-digit-to-low-double-digit milligram vials. Ipamorelin listings more often appear in smaller vial sizes, priced as though the lower total mg count justifies a lower sticker price on its own.

That difference in typical vial size is exactly why a tesamorelin vs ipamorelin cost comparison based on sticker price alone is misleading. A $60 tesamorelin vial and a $60 ipamorelin vial are not “the same price” in any useful sense unless the mg content behind each $60 figure is also checked.

Comparing Sticker Price Isn’t Enough

Consider two hypothetical listings, one for each compound, at vial sizes commonly seen in this category:

ListingVial sizeListed priceCost per mg
Tesamorelin (hypothetical)10 mg$150$15.00
Ipamorelin (hypothetical)5 mg$45$9.00

Read as sticker prices, the tesamorelin vial costs more than three times the ipamorelin vial. Read as cost per mg, the gap narrows to less than double. Both statements are true, but they answer different questions — one describes what leaves the buyer’s account for that vial, the other describes what each milligram of labeled compound costs once the vial size is factored out.

Normalizing to Cost Per Mg

The formula for this normalization is unchanged from any single-compound comparison:

cost per mg = total vial price ÷ mg labeled on the vial

Worked example, tesamorelin: a vial listed at $150 with 10 mg labeled content gives 150 ÷ 10 = $15.00 per mg. Worked example, ipamorelin: a vial listed at $45 with 5 mg labeled content gives 45 ÷ 5 = $9.00 per mg. Rechecking both: 150 divided by 10 is 15, and 45 divided by 5 is 9, so the per-mg figures above hold.

This is the number that actually supports a tesamorelin vs ipamorelin cost comparison, because it strips out the effect of vial size and leaves only the price attached to a fixed quantity of labeled compound. The underlying reference material on HEEZ Research lays out the same vial-size and labeling terminology this per-mg calculation depends on, which is worth checking before assuming two listings are using the term “vial” the same way.

Why the Two Compounds Rarely Land at the Same Per-Mg Figure

Even after normalizing to cost per mg, tesamorelin and ipamorelin listings tend not to converge on a shared number, for reasons that have nothing to do with either compound’s chemistry:

  • Typical dosing scale differs. Listings for compounds commonly used in smaller per-administration amounts are frequently sized and priced around smaller vials, which changes the fixed-cost portion of the per-mg calculation relative to a compound sold in larger vials.
  • Synthesis and sourcing cost. Different peptides carry different production costs at the manufacturing stage, and that cost difference passes through to listed price independent of vial size.
  • Bundle structure. Some sellers bundle ipamorelin with other short peptides in a single listing price, which makes isolating a clean per-mg figure harder than it is for a single-compound tesamorelin vial.
  • Purity and testing claims. As with any peptide category, a listing that references third-party testing tends to sit at a different price point than one that does not, regardless of which compound is being priced.

None of these factors make one compound’s per-mg figure “wrong” relative to the other. They just mean a tesamorelin vs ipamorelin cost comparison is really a comparison of two independently priced markets, not two versions of the same pricing curve.

Reconstitution Math Doesn’t Change the Underlying Comparison

Once a vial is reconstituted with bacteriostatic water, the resulting concentration is a separate calculation from anything covered above: concentration = vial mg ÷ mL of water added. A 10 mg tesamorelin vial reconstituted with 2 mL of water yields 10 ÷ 2 = 5 mg/mL. A 5 mg ipamorelin vial reconstituted with 2 mL of water yields 5 ÷ 2 = 2.5 mg/mL. Checked again: 10 divided by 2 is 5, and 5 divided by 2 is 2.5.

Neither of those concentration figures changes the cost-per-mg numbers calculated earlier — reconstitution spreads a fixed amount of compound across a volume of liquid, it doesn’t change what was paid for that compound. Readers working through vial-to-concentration math for either compound can cross-check the arithmetic against a tool like peptcalc.com once a vial size and diluent volume are set.

A Consistent Way to Run the Comparison

The same three-step check applies regardless of which two compounds are being compared:

  1. Confirm each listing’s mg figure is the labeled vial content, not a bundle total.
  2. Confirm both prices are captured under the same shipping assumption — either both included or both excluded.
  3. Divide each listing to cost per mg before comparing the two compounds against each other, not before.

For readers tracking how tesamorelin listings specifically are worded and revised over time, peer tesamorelin listing catalogs both follow how this compound’s per-vial and per-mg figures shift across sellers, which is useful context when a tesamorelin figure in a comparison looks out of line with what similar listings show.

Summary

A tesamorelin vs ipamorelin cost comparison built on sticker price alone compares two numbers that were never meant to be compared directly, since the two compounds are typically sold in different vial sizes and different bundle structures. Reducing both listings to cost per mg — using the same shipping and labeling assumptions on each side — is what turns two unrelated sticker prices into a comparison that actually holds up. Reconstitution concentration is a separate calculation entirely, and does not change what either compound cost in the first place.

← All articles